Beta-ig is a secretory protein embodied by fasciclin I-like repeats containing sequences that might bind integrins and glycosaminoglycans in vivo. Expression of Beta-ig is responsive to Transforming Growth Factor-b and the protein is found to be associated with extracellular matrix (ECM) molecules, implicating Beta-ig as an ECM adhesive protein of developmental processes. The spatiotemporal distribution of Beta-ig during various stages of murine development was examined and its ability to support adhesion of various cell types assessed. In situ hybridization of mouse embryos (E12.5-E18.5) indicated a prominent, distinct expression pattern for Beta-ig message in connective tissue. Beta-ig transcripts were abundantly expressed during mesenchymal cell condensation in areas of axial, craniofacial and appendicular primordial cartilage from E12.5 -E14.5. Beginning at E15.5, Beta-ig transcripts appeared in collagen-rich tissues, including dura mater and corneal stroma. During E16.5 -E18.5, Beta-ig transcripts were observed in proliferating chondrocytes and areas of endochondral ossification in joint and articular cartilage formation. Connective tissues expressed Beta-ig transcripts within the nasal septum and surrounding cartilage primordia, and in the pericardium, optic cup, kidney, ovary, esophagus, diaphragm, bronchi, trachea and corneal epithelium, and during cardiac valve formation. These patterns of expression indicate that Beta-ig may be involved in tissue morphogenesis. Cells derived from mesenchyme attached onto a substratum comprised of purified recombinant Beta-ig. Taken together, the results indicate that Beta-ig is expressed principally in collagen-rich tissues where it may interact with cells and ECM molecules, perhaps playing a role in tissue morphogenesis. q
Introduction
The extracellular matrix (ECM) is comprised of collagens, proteoglycans and non-collagenous glycoproteins that are crucial for development of multicellular organisms, where tissue morphogenesis is dependent on numerous and varied contacts of ECM molecules and cells (Blaschuk and Holland, 1994) . As new ECM molecules are investigated, information regarding their spatiotemporal expression is anticipated to provide a better understanding of their physiological function. Fairly recently, a gene responsive to Transforming Growth Factor-b (TGF-b) was discovered by differential screening of an adenocarcinoma cDNA library. The newly identified gene, named TGF-b Induced Gene-Human Clone 3, encodes a 683 amino acid secretory protein designated Beta-ig (bIG-H3) (Skonier et al., 1992) .
Beta-ig contains repeating units similar to recurring sequences found in fasciclin-I, a nerve cell growth cone guidance molecule expressed in developing Drosophila (Zinn et al., 1988) . Consensus sequences predicted to bind sulfated glycosaminoglycan (Cardin and Weintraub, 1989) were discovered near the central portion of Beta-ig and may be functional because mammalian expressed recombinant Beta-ig binds heparin -agarose (Billings et al., 2002; Ferguson et al., 2003) . Within the fasciclin I-like repeats are sequences Arg-Gly-Asp (Pierschbacher and Ruoslahti, 1984) , Asn-Lys-Asp-Ilu-Leu and Glu-Pro-Asp-Ilu-Met (Kim et al., 2000b ) that possibly mediate binding to members of the integrin superfamily of cell surface adhesion receptors. Additionally, Beta-ig bound collagens in vitro (Hashimoto et al., 1997) , suggesting that Beta-ig may link cells and molecules of the ECM.
Immunochemistry and protein sequence analyses has detected Beta-ig in skin (LeBaron et al., 1995) , cornea (Escribano et al., 1994; Hirano et al., 1996) , bladder smooth muscle (Billings et al., 2000) and as a component of elastic fibers (Gibson et al., 1996) and developing and adult myotendinous junctions (MTJ) (Ferguson et al., 2003) . The distribution of Beta-ig in adult tissues and the findings that Beta-ig promotes cell adhesion (Kim et al., 2000b; LeBaron et al., 1995) and binds to collagens (Hashimoto et al., 1997; Rawe et al., 1997) fibronectin and glycosaminoglycans (Billings et al., 2002; Ferguson et al., 2003) suggests that Beta-ig might play roles in development processes and tissue modeling. The Beta-ig gene maps to human chromosome 5q31, a region proposed to contain aberrations leading toward the development of tumors, and corneal and muscular dystrophies (see Section 3). However, the normal physiologic function of Beta-ig and mechanisms that may mediate its possible role in various pathogenicities are not clear. Anticipating that developmental processes occurring concurrently with changes in expression patterns of Beta-ig will help to reveal physiological functions, we performed a developmental study regarding the expression patterns and cell adhesion activity of Beta-ig.
The current study documents that Beta-ig transcript is expressed in connective tissue, various epithelial and muscle tissue, and in chondrogenic tissue destined for cartilage or bone morphogenesis. In addition, recombinant Beta-ig promoted adhesion of cell types derived from mesenchyme but not epithelium. The results of this study identify putative functions of Beta-ig in mammalian embryonic processes in vivo. Expression patterns of Beta-ig during development, and its adhesive activity on mesenchyme-derived cells are consistent with an emerging picture that suggests Beta-ig links cells to molecules of the ECM. Fig. 1 is an analysis of the cDNA deduced amino acid sequence of Beta-ig. Schematically identified are four internal repeats sharing homology with fasciclin I (Skonier et al., 1992; Zinn et al., 1988) . Our analysis revealed that Beta-ig contains two putative heparinbinding sequences within the third fasciclin-like repeat. These potential heparin-binding motifs may be functional because human recombinant Beta-ig binds to heparinagarose in vitro (Ferguson et al., 2003) . Additionally, an Arg-Gly-Asp sequence is within the fourth fasciclin-like repeat (Skonier et al., 1992) and the sequences Asn-LysAsp-Ile-Leu and Glu-Pro-Asp-Ile-Met, reported to mediate cell adhesion (Kim et al., 2000b) are within the second and fourth fasciclin-like repeats, respectively. An antisense riboprobe corresponding to the region indicated ( Fig. 1 ) was utilized to screen for specific spatiotemporal patterns of Beta-ig transcripts in mouse embryo tissues (E12.5 -E18.5 p.c.).
Results

Structure and organization of Beta-ig
Shown in
Chondrogenic tissues
Prominent expression of Beta-ig transcripts were detected in chondrogenic tissue destined for cartilage or bone formation. As early as E12.5, pre-chondrocytic mesenchymal cells expressed Beta-ig transcripts abundantly. This expression occurred during the cell recruitment stage for the formation of the cartilaginous model. Beta-ig expression was observed in all developing areas of axial, craniofacial, and appendicular primordial cartilage, including areas of vertebral cartilage ( Fig. 2A) . Cells within the cartilage primordia of E13.5 ribs expressed Beta-ig transcripts (Fig. 2D) , as did cells of the upper limb cartilage (Fig. 2G) . Expression of Beta-ig was also observed in cranial cartilage development (Fig. 2J) . During E12.5, expression of Beta-ig was detected in cranial and vertebral growth plates ( Fig. 3A and D) that represent areas suggestive of cell proliferation (Farnum et al., 1990) .
Expression of Beta-ig transcripts continued until E15.5 when cartilage had taken shape into the future appendicular and axial skeleton. Interior chondrocytes in the E16.5 scapula expressed Beta-ig transcripts (Fig. 4A) . At days E16.5-E17.5, transcripts were observed within specific areas of tissue destined for ossified bone. Beta-ig message Fig. 1 . Schematic of Beta-ig. Illustrated is the protein Beta-ig showing internal repeats I-IV that contain limited homology to fasciclin I. Consensus sequences reported to mediate cell adhesion and their approximate locations are included. The shaded regions in repeat III indicate approximate locations of heparinbinding sequences Lys-Lys-Leu-Arg and Lys-Arg-Gly-Arg. The asterisk denotes the region within Beta-ig corresponding to nucleotide sequence that was used as an in situ hybridization riboprobe. Fig. 2 . Transcripts of Beta-ig are expressed in pre-chondrocytic mesenchymal cells in areas of axial, craniofacial, and appendicular primordial cartilage. At E12.5 Beta-ig transcripts were expressed by mesenchymal cells recruited to the regions of future bone (transverse sections). Darkfield (A, D, G, J) and brightfield (C, F, I, L) photomicrographs indicate the regions where Beta-ig transcripts were detected at areas of cell condensation. E13.5 vertebral bone is denoted by arrows and the notochord identified by double arrows (C). E13.5 rib cartilage primordia expressed Beta-ig transcripts (D and F, asterisk) . Additional areas of expression included E13.5 upper limb cartilage (G and I, area of expression defined by arrows). An increased magnification shows Beta-ig transcripts in E14.5 nasal cartilage primordia (J and L, asterisk) . Representative sense controls (B, E, H, K). Scale bars represent 50 mm. . Beta-ig expression was also evident in the initiation of endochondral ossification in developing limb bones (E17.5 tibia in D, asterisk in F). Areas of intramembranous ossification also displayed Beta-ig transcripts (G). Beta-ig transcripts are detected around the temporal lobe of the embryonic brain at E17.5 (G, I, arrows) but not as evident in brain per se (I, double asterisk). Sagittal sections of E17.5 vertebral column revealed that the dura mater displayed Beta-ig transcripts (J, arrows in L). Marked Beta-ig expression was observed in regions of proliferating chondrocytes, based on histology. Areas lacking Beta-ig message correspond to regions of hypertrophic stage chondrocytes (L, double arrowheads) and the spinal cord (L, asterisk). Representative sense controls (B, E, H, K). Scale bars represent 50 mm. localized to regions of endochondral ossification initiation (Fig. 4D ) and intramembranous ossification, such as the formation of bone surrounding the temporal lobe of the embryonic brain (Fig. 4G) . Based on histological and morphological examination of cartilage models, Beta-ig transcripts appeared abundant in potential regions of proliferating chondrocytes whereas little, if any expression was seen in regions occupied by apparent hypertrophic chondroctyes (Fig. 4J ).
Joint formation
Beta-ig transcripts were identified at joint structures beginning at E16.5 and becoming more evident during E17.5 -E18.5. Transcripts were observed at stages that were concurrent with articulating ends of bones capped with hyaline cartilage. These included cartilage primordia in the mouse footpad at E17.5 ( Fig. 5A ) and between the developing bones in the hindlimbs at E18.5 (Fig. 5D ).
Expression was moderate at E15.5 but steadily increased in intensity in subsequent older embryonic stages.
Fibrous capsules
In kidney, abundant expression of Beta-ig message was observed in the fibrous capsule and the medulla mesenchyme, specifically in regions surrounding the glomeruli formation (E12.5 -E18.5) (Fig. 6A) . The pleural pericardium membrane surrounding the developing heart moderately expressed transcripts (E12.5 -E15.5) (Fig. 6D) . The testes' tunica albuginea dense connective tissue capsule expressed transcripts (E12.5 -E17.5) (Fig. 6G) . Relative to the tunica albuginea, an intense expression of Beta-ig transcripts was evident in the rete testis and the mediastinum of the testes, a local thickening of the tunica albuginea where seminiferous tubules converge before leaving the testes. A striking intensity of the Beta-ig probe was evident within the serosa (connective tissue capsule of the gut wall) (Fig. 6J ). Fig. 6 . Beta-ig transcript localization to connective tissue capsules. Transverse sections reveal Beta-ig message in connective tissue capsules. Areas expressing Beta-ig message include the capsule of an E17.5 kidney (A, C, arrows), as well as the connective tissue surrounding the glomeruli within the medulla (A, C, double asterisk). Adjacent to the kidney is the ovary (A, C, single asterisk), also expressing moderate levels of Beta-ig. Another connective tissue, the pleural pericardium membrane, moderately expressed Beta-ig transcripts (D, F arrows) from E12.5-E15.5 (E14.5 shown). Beta-ig message was also observed in the region of heart valve formation (F, asterisk). Beta-ig expression localized to the connective tissue capsule tunica albuginea in E17.5 testes (G, I arrows) and especially evident at the rete testis and the mediastinum (G, I, arrowheads). The serosa and muscularis externa layers (J, L arrows) of the digestive tract, as well as the lamina propia (J, L, arrowheads) of the E17.5 intestinal tract displayed Beta-ig transcripts. Representative sense controls are indicated in (B, E, H, K). Scale bars represent 50 mm.
Overall, results reveal that Beta-ig expression occurs in regions of the tissues that undergo active morphogenesis or tubular extension, typically involving a remodeling of the associated ECM. A possible role for Beta-ig may be one in mediating cell -cell or cell -substratum contacts that are generated during the development of these tissues.
Epithelial-mesenchymal interactions
Transcripts were observed in the surrounding mesenchyme of the cochlea (E13.3 -E18.5), the corneal epithelium (E15.5 -E18.5), corneal stroma (E15.5 -E18.5), vibrissae (E14.5 -E18.5), and the cartilaginous bronchi of the developing lungs (E12.5 -E18.5). Expression in the cornea began around E15.5 and continued until E18.5, becoming more abundant as development progressed. Transcripts were localized to the corneal stroma and epithelial layers (Fig. 7A ). Near vibrissae, Beta-ig expression was detected mainly in condensed mesenchyme of the dermis surrounding the epithelial layer of the hair follicle (Fig. 7D ). Moderate transcript expression localized adjacent or within the overlying epidermis.
The mesenchyme surrounding the cochlear duct contained Beta-ig transcript levels that peaked at E13.5 and then declined through E18.5 (Fig. 7G) . Beta-ig transcripts in the lung were expressed in early stages moderately, becoming increasingly more intense surrounding the epithelial layer of the developing bronchi by E18.5 (Fig. 7J ). Moderate Beta-ig expression was detected in muscularis externae surrounding the esophagus, mesenchymal tissue surrounding the aorta and the hyaline cartilage rings surrounding the developing trachea (Fig. 7J) .
During development, interactions between mesenchyme and epithelium are involved in tissue morphogenesis and induction of cell differentiation into specified phenotypes. The expression of Beta-ig was coincident with these interactions and was expressed at the highest levels when tissue remodeling was the most active. Again, a role for cell -cell or cell -substratum interactions is indicated.
Connective matter surrounding neural tissue
As observed with most connective tissue within the mouse embryo, robust expression was evident in connective Fig. 7 . Beta-ig transcripts localize to areas of epithelial-mesenchymal interactions. Transverse sections (A, C) show the corneal epithelium (arrowheads) and stroma (arrows) from E16.5-E18.5 (E16.5 shown) and mesenchyme in developing vibrissae (D, F, arrows) from E14.5-E18.5 (E18.5 shown). Moderate expression of Beta-ig mRNA was detected in the epithelium surrounding the hair follicle (D, F, double arrowheads). Beta-ig transcripts were detected in the surrounding mesenchyme of developing cochlea (E13.3-E18.5) (G, I, arrows; E17.5 shown), in the mesenchyme surrounding the epithelial layer of the developing cartilaginous bronchi of the lungs (E12.5-E18.5) (J, L; single arrowhead) and in the cartilage surrounding the trachea (J, L, double arrow, E15.5 shown). Expression was also observed in the mesenchyme and smooth muscle layers surrounding the aorta (J, L, single arrow) and esophagus (J, L, double arrowhead). Representative sense controls (B, E, H, K). Scale bars represent 50 mm.
tissue surrounding specific neural tissue. During E14.5 -E18.5 expression localized to the dura mater the optic nerve stalk and the sclera of the eyeball (Fig. 8A) . The sclera, composed of fibroblasts and dense fibrous collagen tissue intermingled with fine elastic fibers, fuses with the dural and arachnoid sheaths of the optic nerve during these stages. At E14.5 Beta-ig transcripts were observed throughout the trigeminal ganglia (Fig. 8D ) and the epithelial wall of Rathke's pouch within an area known for intense cell proliferation (Fig. 8G) .
Muscle tissue
Beta-ig transcripts were evident in the epimysium surrounding muscle fiber bundles in later stages (Fig. 9A) . In more specialized muscle tissue such as the diaphragm, Beta-ig transcripts were abundantly expressed along the entire surface from E15.5 -E17.5 (Fig. 9D) . Cardiac valves in the embryonic heart expressed Beta-ig transcripts from E12.5, increasing to a maximum intensity at E14.5 (Fig. 9G) . Transcript levels in the valves then began a slight decline from E15.5 until E18.5. Transcripts were also evident in all sections where muscle contacted developing bone, as illustrated in the muscle connecting to the vertebral bone at E17.5 (Fig. 9J ). An expanded study has demonstrated that Beta-ig protein is expressed markedly at developing and adult MTJ (Ferguson et al., 2003) . A summary of developing mouse tissues expressing Beta-ig is presented in Table 1 .
Beta-ig in vitro mediates mesenchymal cell adhesion
The distribution of Beta-ig mRNA throughout development was concordant with a possible role of Beta-ig protein in cell adhesion. The tissue distribution suggests that cells interacting with Beta-ig may include non-differentiated mesenchymal cells and also differentiated cell types including chondrocytes, osteoblasts, fibroblasts, skeletal muscle cells, and epithelial cells. Therefore, we investigated whether a substratum comprised of purified recombinant Beta-ig would support the attachment of various cell types. Here, solid phase binding assays were performed with cell types that are suggested or known to express Beta-ig. As a control cell type, primary human dermal fibroblasts were included because they bind Beta-ig (LeBaron et al., 1995) . To prevent endogenous protein synthesis from affecting results, cells were pre-treated with cycloheximide. The results demonstrate that a substratum comprised of recombinant Beta-ig (full characterization described in Ferguson et al. (2003) ) supported adhesion of osteoblasts, stromal fibroblasts and skeletal muscle cells. The notable exception was corneal epithelial cells, albeit the epithelial cells readily attached to type I collagen (Fig. 10) . Few, if any cells attached to BSA. Fig. 8 . Beta-ig expression in the dura mater and trigeminal ganglia. Beta-ig transcripts localize to the dura mater (A, C, arrow) surrounding the developing optic nerve stalk (asterisk). Expression was observed from E14.5 to E18.5 (E17.5 shown). Transcripts were observed within the eye sclera (A, C, double arrowhead) and throughout the trigeminal ganglia (D) with an apparent increased signal density in the caudal half of the trigeminal ganglia (D, F arrow) (E14.5 shown). Rathke's pouch displayed Beta-ig message (G), localizing to areas known for cellular and vascular proliferation surrounding the lumen (I, arrows) (E14.5 shown). Representative sense controls (B, E, H). Scale bars represent 50 mm.
Discussion
This study reveals that Beta-ig expression is spatially restricted during development, localized principally within and near tissues enriched in connective tissue molecules such as collagens and that Beta-ig serves in vitro as an adhesion substratum for some (but not all) cell types that correlate with spatial expression of Beta-ig. A developmental model was chosen because tissue modeling involves extensive changes in ECM biosynthesis that can be correlated with developmental events and thus facilitate discovery of function. This study tested for Beta-ig transcripts during the developmental stages of E12.5-E18.5. These stages of development were selected because RNA blot analysis indicated that Beta-ig transcripts were not expressed until after E12 of murine development (Skonier et al., 1992) and Beta-ig was observed in ocular tissue at E18.5 (Schorderet et al., 2000) . Results suggest that Beta-ig plays important role(s) in the development processes of various embryonic tissues, particularly tissues of mesodermic and neural crest origin, at specific times when critical morphogenic events occur. A general conclusion can be drawn that Beta-ig appeared closely-associated with mesenchyme per se or with tissues derived from mesenchyme, such as cartilage and bone. Embryonic mesenchymal cells (EMCs) are fundamentally important in the overall classification of supportive tissue. Not only can EMCs self-replicate, they are also capable of differentiating into fibroblasts, chondroblasts, myoblasts, and osteoblasts (Bianco et al., 1998) . Our results suggest that Beta-ig transcripts appeared in areas occupied by EMCs during the development of the mouse embryo.
Generally, Beta-ig transcripts were detected during several steps leading toward formation of mature bone, including primary morphogenesis of the cartilage model in earlier stages and subsequent chondrogenesis and ossification. The formation of bone consists of a series of cellular activities, including chemotactic, proliferative, and differentiative stages. On the tissue level, this consists of a sequence of modeling and remodeling events, until the final mature structure is formed (Ballabriga, 2000) .
Transcripts of Beta-ig were observed during the formation of axial and appendicular bones, most notably Fig. 9 . Beta-ig expression in muscle tissue. Beta-ig transcripts were expressed in the epimysium (A, C, arrows) surrounding muscle fiber bundles at E17.5 and over the entire area of the diaphragm (D, F, arrows), remaining constant in diaphragm expression levels from E15.5-E17.5 (E17.5 shown). In early cardiac muscle tissue expression was abundant in cardiac valve formation (G, I). E14.5 heart valves (I, single arrow) are near a developing rib (I, double arrowhead). MTJ also expressed Beta-ig transcripts (J, L, arrows; E17.5 vertebral bone, the asterisk denotes spinal cord, double arrowhead indicates the ventral vertebral bone). Representative controls sections are illustrated in (B, E, H and K). All results listed above are transverse sections. Scale bars represent 50 mm.
at stages of cell recruitment, increased matrix secretion, and differentiation. Axial and appendicular bones of the skeleton are derived from the mesoderm. Their development is indirect in that they undergo endochondral ossification (Ballabriga, 2000; DeLise et al., 2000) , a process where a cartilage model of chondrocytes exists prior to differentiation and osteogenesis. Marked expression of Beta-ig was observed during the assembly and recruitment of mesodermic cells when forming the cartilage primordial model. During the proliferative phase of chondrocytes prior to bone formation, chondrocytes secrete large amounts of ECM, contributing to the growth and expansion of the cartilage model (Moss and Moss-Salentijn, 1983) . Areas that appeared to contain proliferating chondrocytes expressed transcripts of Beta-ig and expression was reduced significantly in subsequent hypertrophic stages. It should be noted here, however, that both of these conclusions are based on the histology of the cells within the tissue and not by more conclusive tests such as the use of differentiation markers or BRDU incorporation. During the late stages of bone development (E17.5 -E18.5), Beta-ig transcripts were again detected. Additionally, in later stages of joint formation, such as articulations between bones, a relative abundance of Beta-ig transcripts was evident.
Previous data showing that in vitro Beta-ig supports attachment of chondrocytes (Ohno et al., 1999) and binds collagen (Hashimoto et al., 1997; Rawe et al., 1997) is consistent with the expression of Beta-ig transcripts in the regions detected in the present study. Expression of Beta-ig mRNA may be regulated by factors influencing cell differentiation. Treatment of human bone marrow stromal cells in vitro with dexamethasone promotes osteogenic differentiation. Relative to several different connective tissue cell types, dexamethasone treated bone marrow stromal cells exhibited a marked decrease in Beta-ig mRNA and a suggestion was put forth that Beta-ig is a negative regulator these cells (Dieudonne et al., 1999) .
The expression of Beta-ig transcripts in cartilage and bone formation was not limited to the axial and appendicular skeleton however, as the synthesis of transcripts was also conspicuous in mesenchyme of neural crest origin. Unlike the endochondral ossification process observed in limbs, the cranial, facial flat bones and mandibles evolve directly in areas of vascularized neural crest mesenchyme in a process called intramembranous ossification (Ballabriga, 2000) . It is speculated that TGF-b1, also expressed in neural crest mesenchyme, increases the levels of ECM molecules that may contribute to the migration of neural crest cells and their subsequent differentiation in becoming craniofacial mesenchyme (Heine et al., 1987) . In a number of different cell types, Beta-ig expression is induced by TGF-b1 (Dieudonne et al., 1999; Gilbert et al., 1998; Hashimoto et al., 1997; Kim et al., 2000a; LeBaron et al., 1995; Skonier et al., 1992 Skonier et al., , 1994 and may therefore be involved in mediating some of the varying effects that TGF-b1 evokes. Spatiotemporal similarities between Beta-ig and TGF-b1 expression were striking in the mouse embryo, and an accumulation of Beta-ig expression was generally observed in or near tissues whose cells express TGF-b1 in vivo. Indeed, the expression patterns of Beta-ig appeared to essentially mirror previously documented TGF-b1 expression within the mouse embryo (Heine et al., 1987; Thompson et al., 1989) .
Beta-ig mRNA was detected in the dural layers surrounding the brain, the spinal cord, and the optic nerve; structures that correspond to areas of limited TGF-b1 expression (Heine et al., 1987) . Within brain tissue itself, the paucity of Beta-ig expression is consistent with previous analysis of brain tissue (Skonier et al., 1992) and paralleling expression patterns of TGF-b1 (Heine et al., 1987) . However, Beta-ig transcripts were localized to specific tissues typically identified with sensory nerve innervation and sensation. The trigeminal nerve contributes to sensation received from the skin of the face and forehead, the cornea, the mucosa of the oral and nasal cavities, and from the dura mater (Barr and Kiernan, 1988) . We observed Beta-ig transcripts in the dura mater, regions of developing vibrissae, the cornea, and the tongue. All of these tissues are infiltrated with nerves emanating from one of the three branches of Cranial Nerve V (trigeminal nerve). Interestingly, Beta-ig transcripts were found within the trigeminal ganglia itself. Expression was observed in the caudal half of the ganglia, an area where the ophthalmic (V 1 ), maxillary (V 2 ), and mandibular (V 3 ) nerve divisions exit. Expression of Beta-ig within the trigeminal ganglia suggests a role in specific neuronal cell and processes movement; however, whether Beta-ig is involved with neural cell migration remains an open question.
Although most Beta-ig message was mainly observed in tissue of mesenchymal origin, in some instances, Beta-ig transcripts localized to epithelia where critical interactions between mesenchyme and epithelial tissue occur, including development of vibrissae, bronchi of the lung, and the cornea. In tissue containing vibrissae, Beta-ig expression was mainly present in the condensed mesenchyme of the dermis surrounding the epithelial layer of the hair follicle. Beta-ig expression in lung was similar in that expression was also in mesenchyme surrounding the epithelial layer of the developing bronchi.
Expression of Beta-ig was evident in areas of angiogenesis and the formation of vasculature. Connective tissue walls of several large vessels, including the vena cava and aorta, expressed Beta-ig, as did areas rich in capillary infiltration, such as endochondral and intramembranous ossification. Beta-ig transcripts appeared during the formation of primordial heart valves, which are derived from the mesenchyme of endocardial cushion tissue. The endocardial cushions form in the early heart as swellings rich in types I and III collagen, fibronectin, and proteoglycans (Fitzharris and Markwald, 1982) . This particular connective tissue is involved in the modeling of the heart, leading to the partitioning of the atrioventricular canal and the formation of the connective tissue framework of the cardiac valves (Icardo and Manasek, 1984) .
Beta-ig protein has been detected at cell bodies and within their stroma (Ferguson et al., 2003; LeBaron et al., 1995) . These localizations, considered together with the presence of putative cell-binding sequences in Beta-ig, suggested a biological role in cell adhesion. Thus, utilizing recombinant Beta-ig in cell attachment assays the attachment of a subset of cell types that might express Beta-ig mRNA during mouse development was examined. Adhesion was tested under conditions restricting biosynthesis of endogenous proteins by cycloheximide. Results demonstrated that in vitro, a substratum comprised of Betaig supported the adhesion of several cell types derived from mesenchyme, suggesting that during developmental processes, Beta-ig may play a role in tissue organization and modeling, perhaps bridging interactions between cells, collagens and proteoglycans.
Generally, the principal expression patterns of Beta-ig transcripts during murine development suggest Beta-ig protein associates with several mesenchymal and epithelial cell types. Additionally, the detection of Beta-ig transcripts within collagen-rich tissues is consistent with the findings that in vitro, Beta-ig may associate with collagen types I, II, IV and VI (Hashimoto et al., 1997; Rawe et al., 1997) . Betaig may link collagens and various other components of the ECM and cells, including fibroblasts (LeBaron et al., 1995) , bladder cells (Billings et al., 2000) , osteogenic cells (Dieudonne et al., 1999; Ohno et al., 1999) , and epithelial cells (Kim et al., 2000b) . Indeed, in bovine tissues Beta-ig was localized near Type VI collagen and fibrillin-containing myofibrils near elastic fibers (Gibson et al., 1996; Gibson et al., 1997) , findings consistent with a possible role in cell adhesion and tissue structure. Interestingly osteoblasts express a closely-related protein named periostin that localizes specifically to the developing periosteum and periodontal ligament, suggesting that proteins in the Beta-ig family play a role in development and tissue morphogenesis (Horiuchi et al., 1999) .
Although the normal, physiological function of Beta-ig is not yet well understood, accumulating evidence suggests that altered expression of Beta-ig contributes toward the development of several different pathologies. The human Beta-ig gene is localized to chromosome 5q31, where a deletion of this locus is the most common lesion found in myelodysplastic syndrome subtypes and many human leukemias. Consequently, 5q31 has been suggested to contain a tumor suppressor gene (Pedersen and Jensen, 1991) of which Beta-ig is a candidate (Skonier et al., 1992 (Skonier et al., , 1994 . The 5q31 locus is also proposed to contain genes in which a lesion may contribute to Limb Girdle Muscular Dystrophy Type 1A (Horrigan et al., 1999) . Interestingly, anti-Beta-ig antibody exhibited a marked staining at MTJ in embryonic and adult tissues (Ferguson et al., 2003) . Thus the Beta-ig gene and its protein product are spatially poised to possibly contribute to the development of muscular disorders. Along these lines, mutations in the Beta-ig gene that results in single amino acid changes in Beta-ig protein are causative in the development of corneal dystrophies (Korvatska et al., 1999; Munier et al., 1997) . Aberrant expression of Beta-ig may contribute toward development of vascular lesions (O'Brien et al., 1996) , and fibrous tissue accumulation in the juxtaglomerular apparatus in experimentally induced diabetic rats (Gilbert et al., 1998) . Beta-ig serves as an adhesion substratum for various types of cells derived from mesenchyme (this study, but also see Hashimoto et al. (1997) and LeBaron et al. (1995) ) and Beta-ig associates with collagens (Hashimoto et al., 1997; Rawe et al., 1997) fibronectin and glycosaminoglycans (Billings et al., 2002; Ferguson et al., 2003) . These findings, together with the possibility that mutant Beta-ig plays a role in corneal and muscular dystrophies, further supports the probability that Beta-ig plays important structural and cell adhesion roles in tissue development and maintenance. 
Preparation of embryonic tissue for in situ hybridization
Mouse embryos, days E12.5 -E18.5, were fixed in 10% neutral formalin overnight at ambient temperature and processed for paraffin embedment as previously described (Wheeler et al., 1998) . Briefly, embryos were washed in phosphate buffered saline (PBS) and dehydrated through graded ethanols and xylene infiltrated. Embedded embryos were cut into 10 mm-thick sections, mounted on microscope slides in a 42 8C waterbath and then baked 12 h at 45 8C and re-hydrated in PBS prior to prehybridization.
Riboprobe construction
First strand cDNA was synthesized from isolated total mouse heart RNA using oligo-dT primers. The cDNA was subjected to PCR using the sense and antisense primers 5 0 CGAACTGCTCAATGCTCTCCGC3 0 and 5 0 CCCCGAT-GCCTCCGCTAACC3 0 , respectively. Specific RNA probes for Beta-ig were developed using a 1259 bp cDNA strand corresponding to nucleotides 540-1798 (GenBank accession number L19932). A BLAST search (Altschul et al., 1990 ) of our probe sequence was performed and homology to other gene sequences was not detected. The 1259-bp amplified product was subcloned into pGEM-T and the plasmid linearized with NotI (antisense) and SacII (sense) to obtain DNA templates.
35 S-rUTP-labeled antisense and sense probes were transcribed from the cDNA using the T7 and SP6 RNA Polymerase Riboprobe Combination System.
In situ hybridization
In situ hybridization was performed as previously described (Wheeler et al., 1998) . Care was taken to keep all tissue sections and laboratory equipment free of active ribonuclease and DEPC-treated water was used in all prehybridization washes. Unless otherwise specified, all procedures were performed at ambient temperature. Paraffinembedded embryo sections on slides were de-paraffinized in xylene and rehydrated through graded ethanols. The sections were immersed in 4% paraformaldehyde, pH 7.4, for 5 min and then washed in fresh PBS. Sections were treated for 8 min with 20 mg/ml Proteinase K and immersed again for 5 min in 4% paraformaldehyde solution. Positive charges on the tissue sections were blocked with acetic anhydride in 0.1 M triethanolamine and sections immersed in 2 £ SSPE and dehydrated in graded alcohol in preparation for probe hybridization.
Probes were diluted in Prehybridization Solution A (comprised of 2 £ SSPE, 50% formamide, 5 mM EDTA, 20 mM DTT and 20 mM Tris, pH 7.4), supplemented with 1 £ Denhardt's reagent, containing dextran sulfate to yield 10% (w/v) and 500 mg/ml yeast tRNA. A 50 ml volume of Prehybridization Solution A containing 525,000 dpm/slide was spread over each embryo section, then hybridizations protected with glass coverslips continued for 16 h at 50 8C in a moist chamber, followed by rinsing with 2 £ SSC and a 10-minute wash with Prehybridization Solution A at 60 8C. Hybridized sections were treated with 10 mg/ml RNase A at 37 8C for 30 min, followed by a rinse with 2 £ SSC (30 min), 0.1 £ SSC (15 min, 608C) and 0.1 £ SSC (30 min). Sections were dehydrated in graded ethanols containing 0.3 M ammonium acetate, dried overnight, and dipped in NTB-2 photographic emulsion. All sections were exposed for 3 weeks at 4 8C. In some experiments, serial sections of tissue were counterstained with methyl green. Sections were analyzed by darkfield and phase-contrast microscopy with a Nikon Eclipse 600.
Cell culture
Cell types used in this investigation were cultured in growth media supplemented with 50 mg/ml each of penicillin and streptomycin sulfate. Cultures were maintained at 37 8C in 95% ambient air and 5% CO 2 . All cell types were tested for mycoplasma by an ELISA-based methodology (Russell et al., 1975 ) and found to be negative.
Corneal epithelial cells
An SV-40 transfected corneal epithelial cell line was utilized in attachment assays. Previous characterization of this cell line showed similar properties to normal corneal epithelial cells, including desmosome formation, keratin expression, and stratification (Araki-Sasaki et al., 1995) . Corneal epithelial cells were cultured in SHEM medium composed of a 1:1 mixture of DMEM and Hams F-12 media. SHEM medium was supplemented with insulin (5 mg/ml), choleratoxin (1 mg/ml), human EGF (10 ng/ml), gentamycin (40 mg/ml), and 10% FBS.
Stromal fibroblasts, dermal fibroblasts, and myofibroblasts
Rabbit corneal fibroblast strains (provided by J.V. Jester, Univ. Texas Southwestern Medical Center) and primary human dermal fibroblasts were cultured as described previously (Barry-Lane et al., 1997; LeBaron et al., 1995) . TRK-36 corneal fibroblasts appear similar to normal corneal fibroblasts, maintaining a stellate, keratocyte morphology when grown in the absence of serum. TRK-43 corneal fibroblasts show evidence of a wound response phenotype and features that are characteristic of myofibroblasts, expressing a-smooth actin under serum-free conditions.
Murine myoblasts and osteoblasts
C2C12 murine myoblasts (ATCC number CRL-1772) were cultured as previously described (Yaffe and Saxel, 1977) . Primary myoblasts were isolated from the quadricep muscle obtained from mouse embryos (CD-1 strain, day 17.5). The tissue was dissected from both hindlimbs, trypsinized for 10 min at 37 8C, and seeded onto a substratum comprised of 50 mg/ml type I collagen flooded with F10 growth medium. Added daily to the F10 growth medium to maintain myoblast population and to prevent differentiation were chick embryo extract (30 ml/ml), insulin (10 ng/ml), bFGF (20 ng/ml) and horse serum to yield a final concentration of 10%. Cells below passage seven were used in solid phase attachment assays. Murine osteoblast 2T3 cells were a gift from Dr Stephen E. Harris, University of Texas Health Science Center, San Antonio and maintained as described (Ghosh-Choudhury et al., 1996) .
Recombinant Beta-ig
Serum-free medium (IS CHO-V-GS) conditioned by Chinese Hamster Ovary (CHO) cells expressing Beta-ig (LeBaron et al., 1995; Skonier et al., 1994) was centrifuged to remove debris. The supernatant was exchanged for water and concentrated over a flow cell YM membrane (cutoff 30,000), lyophilized and stored at 2 20 8C. Beta-ig was purified as previously described (Ferguson et al., 2003) . Coomassie Blue-stained protein acrylamide gels and immunoblot analyses verified that fibronectin and vitronection were not detected (not shown). Bicinchoninic acid assay (Smith et al., 1985) was utilized to determine the concentration of purified Beta-ig for experiments.
Solid-phase cell attachment assay
Substratum comprised of 10 mg/ml Beta-ig was prepared by coating 96-well plates as described (LeBaron et al., 1995) . Wells coated with 10% BSA and 10 mg/ml type I collagen served as control substrata. Sub-confluent cell monolayers were pre-incubated with 10 mg/ml cycloheximide in serum-free media for one hour and detached by the addition of 0.1 M EDTA in PBS. Cells were washed, re-suspended in their appropriate serum-free medium containing cycloheximide and seeded at a density of 4 £ 10 4 per well. After a one-hour incubation, non-attached cells were rinsed from wells. Attached cells were quantified by the addition of WST-1 reagent and recording absorbance at 450 nm. WST-1, a tetrazolium salt, is cleaved by mitochondrial dehydrogenases and is an efficient way to measure cell viability and quantify cell number. To determine statistical significance, three experiments (duplicate wells in each individual experiment)^s.d. were evaluated and significance calculated by paired t-tests. Differences were considered significant when P # 0:05:
Statement of animal use
The care and experimental use of mice in this study was in accordance with the University of Texas at San Antonio's Animal Care Facility guidelines and the International Animal Care and Use Committee.
